Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Competition and efficiency in the end stage renal disease program.

P J Held, M V Pauly

    Journal of Health Economics
    |July 10, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ABO-Incompatible Kidney Transplants: Twice as Expensive, Half as Good.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    A Cost-Benefit Analysis of Government Compensation of Kidney Donors.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Making sense of a complex system: empirical studies of employment-based health insurance.

    International journal of health care finance and economics·2003
    Same author

    Premium variation in the individual health insurance market.

    International journal of health care finance and economics·2003
    Same author

    Community benefits: how do for-profit and nonprofit hospitals measure up?

    LDI issue brief·2003
    Same author

    Financial incentives and drug spending in managed care.

    LDI issue brief·2003
    Same journal

    Competition matters: Uniform vs. indication-based pricing of pharmaceuticals.

    Journal of health economics·2026
    Same journal

    Integrating equity and productivity in health evaluation.

    Journal of health economics·2026
    Same journal

    Income and immunity: The consequences of social security administration reform for childhood infection risk.

    Journal of health economics·2026
    Same journal

    When fewer children mean shorter lives: Fertility policy and elderly well-being in China.

    Journal of health economics·2026
    Same journal

    Health dynamics and reporting bias at retirement: An analysis using high-frequency data.

    Journal of health economics·2026
    Same journal

    Intertemporal coordination in volunteer markets.

    Journal of health economics·2026
    See all related articles

    Dialysis facility costs are biased by competitive amenity bias, making efficiency hard to measure. Higher reimbursement increases costs, amenities, and patient well-being, requiring policy decisions on amenity levels.

    Area of Science:

    • Health economics
    • Healthcare management

    Background:

    • Medical service cost functions can suffer from 'competitive amenity bias'.
    • This bias can hinder the identification of factors influencing economic efficiency in healthcare provision.

    Purpose of the Study:

    • To investigate the productivity and potential biases in dialysis facilities.
    • To understand the relationship between reimbursement levels, costs, amenities, and patient well-being.

    Main Methods:

    • Analysis of production or cost functions in dialysis facilities.
    • Qualitative investigation of factors affecting economic efficiency and amenity provision.

    Main Results:

    • Evidence of 'competitive amenity bias' was found in dialysis facilities.

    Related Experiment Videos

  • Difficulty in accurately estimating cost functions due to this bias.
  • Reimbursement levels positively correlate with incurred costs, amenity levels, and patient well-being in competitive markets.

    • Conclusions:

    • Policy decisions are needed to determine optimal reimbursement levels.
    • Societal preferences for amenity delivery to public program beneficiaries must be considered.
    • Balancing cost, amenity, and patient well-being is crucial in healthcare policy.